We always love hearing feedback from users of our tools and services, especially when they share with us how they've used the CSD to advance their research. So it was great to hear from Prof. Alexander Dömling and Assis. Prof. Constantinos Neochoritis from the University of Crete, who used the CSD and CCDC tools, including ConQuest, Mogul, CSD-CrossMiner and IsoStar, in their recent research. Read their story below...
Continue reading…This year’s 3D print contest was one of best so far with eight very impressive entries!
The winner is chosen from all the entries submitted via Twitter using the hashtag #CSD3DPrint, combining the number of social media engagements (likes and retweets) and scores from our expert panel of judges. The winner will receive a $50 gift card to Shapeways.
Continue reading…In a new study published in Crystal Growth & Design, researchers from CCDC, in collaboration with the University of Leeds, Britest Limited, Pfizer and GSK, introduced a new workflow that brings together existing and novel approaches in the assessment and prediction of particle properties important to the formulation and manufacture of pharmaceuticals.
Continue reading…In a new review, coinciding with the millionth structure being added to the CSD, researchers from the Cambridge Crystallographic Data Centre (CCDC) have highlighted the incredible impact this database has had on the scientific fields of Physics, Chemistry and Biology since its inception. This success of the crystallographic community in sharing data has been fundamental to advances in the structural sciences. The future of the database also looks to be strong, as the demand for big data, machine learning and the design of new materials with tailored properties continues to increase.
Continue reading…We are delighted to announce that today we have launched our new logo as part of our plans to refresh our visual identity.
Continue reading…Barcelona and Cambridge, UK, 26th June 2019. The Cambridge Crystallographic Data Centre (CCDC) and Pharmacelera have reached an agreement to perform a joint research project to reinforce the results obtained by structure-based in-silico technologies via ligand-based tools. GOLD, CCDC’s docking software used to identify small molecules binding a therapeutic target and PharmScreen®, Pharmacelera’s flagship software, that identifies novel candidates by reference to the properties of known ligands, will be used together to improve the quality of virtual screening campaigns.
Continue reading…
Cambridge UK, 6 June 2019. CCDC (The Cambridge Crystallographic Data Centre), world-leading experts in structural chemistry data, software and knowledge for materials and life science research and application, today announced a huge milestone for structural chemistry with the addition of the millionth structure into the Cambridge Structural Database (CSD).
Continue reading…The CCDC is delighted to report that the winner of the 2019 edition of the CCDC Chemical Crystallography Prize for Younger Scientists is Dr Sihai Yang from the University of Manchester.